Anti-Human CD161 Monoclonal Antibody (AF647 Conjugated) | DL21838F

Anti-Human CD161 Monoclonal Antibody (AF647 Conjugated) | DL21838F | Gentaur UK, US & Europe Distribution

Host: Mouse

Synonyms: CLEC5B, NKRP1A, NKR-P1A, HNKR-P1a, KLRB1

Reactivity: Human

Application: FCM

Background: CD161 is a type II transmembrane glycoprotein, also known as NKR-P1A, that is expressed as a 40-44 kD homodimer. It is a member of the C-type lectin superfamily. CD161 is expressed on a majority of NK cells, NKT cells, and subsets of peripheral T cells and CD3+ thymocytes. It has been reported that Th17 cells are a subpopulation of CD4+CD161+CCR6+ cells. While the biological function of CD161 is not clear, it has been suggested to serve either as a stimulatory receptor or to inhibit NK cell-mediated cytotoxicity and cytokine production. LLT-1 (lectin-like transcript-1, also named as osteoclast inhibitory lectin or CLEC2D) is the ligand of CD161.

Concentration: N/A

Conjugation: AF647

Buffer: PBS with 0.05% Proclin300, 1% BSA

Clone: HP-3G10

Isotype: Mouse IgG1, κ